Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by Cellectis S.A. for the month of May 2025. The filing, dated May 6, 2025, serves primarily to distribute a press release (Exhibit 99.1) to U.S. investors. The registrant is headquartered in Paris, France, and files annual reports under Form 20-F.
Financial Metrics
The provided filing text does not contain specific financial data. There are no disclosed values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The filing acts as a conduit for a press release rather than a financial statement.
Material Changes
No material changes to financial position or operations are detailed in the text of this Form 6-K. The document does not provide comparative data against prior periods.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, risk factors, or details on contingencies. The content is limited to the cover page and exhibit index referencing a press release.
Key Facts for Investor Verification
- The filing references a press release dated May 6, 2025, as Exhibit 99.1, which is not included in the provided text.
- No financial metrics or operational updates are present in the cover document itself.
- Investors must review the full text of the referenced press release to understand the specific announcement triggering this filing.
- The report was signed by André Choulika, Chief Executive Officer.